Cerus Corp - ESG Rating & Company Profile powered by AI
Browse to the end of the page for potential risks for Cerus Corp based on industry, location and size. The webpage includes a Q&A section for Cerus Corp. This analysis of Cerus Corp is assembled by All Street Sevva using proprietary AI.
Cerus Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.6; made up of an environmental score of 0.0, social score of 1.6 and governance score of 3.2.
1.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1682 | Viracta Therapeutics Inc | 1.7 | Low |
1682 | Werewolf Therapeutics Inc | 1.7 | Low |
1715 | Cerus Corp | 1.6 | Low |
1715 | CareDx Inc | 1.6 | Low |
1715 | Catalyst Biosciences Inc | 1.6 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Cerus Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Cerus Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes Cerus Corp report the average age of the workforce?
Sign up for free to unlockDoes Cerus Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Cerus Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes Cerus Corp disclose cybersecurity risks?
Sign up for free to unlockDoes Cerus Corp offer flexible work?
Sign up for free to unlockDoes Cerus Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Cerus Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Cerus Corp conduct supply chain audits?
Sign up for free to unlockDoes Cerus Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Cerus Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes Cerus Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes Cerus Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Cerus Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Cerus Corp disclose water use targets?
Sign up for free to unlockDoes Cerus Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid Cerus Corp have a product recall in the last two years?
Sign up for free to unlockDoes Cerus Corp disclose incidents of discrimination?
Sign up for free to unlockDoes Cerus Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Cerus Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Cerus Corp disclose parental leave metrics?
Sign up for free to unlockDoes Cerus Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Cerus Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Cerus Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes Cerus Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Cerus Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Cerus Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Cerus Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes Cerus Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Cerus Corp disclose its waste policy?
Sign up for free to unlockDoes Cerus Corp report according to TCFD requirements?
Sign up for free to unlockDoes Cerus Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Cerus Corp disclose energy use targets?
Sign up for free to unlockDoes Cerus Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Cerus Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Cerus Corp
These potential risks are based on the size, segment and geographies of the company.
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. The company was incorporated in 1991 and is headquartered in Concord, California.